#Germany #Berlin #AI Healthcare #Coreline Soft #Lung Cancer Screening

Coreline Soft's AI Solution for Lung Cancer Screening

In a significant advancement for lung cancer screening, Coreline Soft has partnered with Charité - Universitätsmedizin Berlin to implement its innovative artificial intelligence (AI) solution for Lung Cancer Screening (LCS). This collaboration marks a pivotal entry for Coreline Soft into Germany's prominent clinical center, addressing the growing importance of standardized infrastructure within the lung cancer screening market.

About Charité - Universitätsmedizin Berlin

Charité is the largest university hospital in Germany and is globally respected, holding the 7th position according to Newsweek's 2025 rankings. Managed jointly by the federal government and the state of Berlin, Charité serves not only as an advanced medical facility but also as a reference point for national health policies and clinical guidelines.

The AVIEW LCS Plus Solution

The centerpiece of this partnership is the AVIEW LCS Plus, an advanced AI product optimized for low-dose computed tomography (LDCT) screening. This cutting-edge solution adds significant value by automatically analyzing lung nodules, chronic obstructive pulmonary disease (COPD), and coronary artery calcification (CAC) from a single LDCT scan, thus enhancing reading efficiency and consistency.

Proven Reliability

The AVIEW LCS Plus has previously undergone rigorous validation through the HANSE project, a national pilot program for lung cancer screening in Germany. The solution has demonstrated operational stability across various multicentric environments, reinforcing its reliability for clinical use.

Transitioning to a National Screening Program

Germany is striding from pilot phases towards a formal national lung cancer screening system. The Federal Joint Committee (G-BA) is set to implement LDCT screening as part of mandatory health insurance benefits in the upcoming semester. As the market pivots towards structured processes, including participant selection, double reading protocols, and quality control, the focus is shifting from individual hospital adoption to broader standardized practices.

Introduction of AVIEW HUB

To align with the stringent requirements, including dual reading protocols and data pseudonymization, Coreline Soft has introduced AVIEW HUB. This centralized platform supports multicentric screening operations by integrating quality control features that ensure compliance and alleviate the manual workload for healthcare personnel.

Coreline Soft's Competitive Edge

Industry experts suggest that Charité's adoption of Coreline Soft's solution signifies a shift from competition based on product performance to one driven by operational infrastructure capabilities. As Germany establishes standardized reimbursement processes, companies like Coreline Soft, which specialize in multicentric operations and hub-based management, are expected to strengthen their global competitiveness in the long run.

The introduction of AI in healthcare, particularly in critical areas like cancer screening, signifies a promising evolution that enhances both operational efficiency and patient outcomes. With its technological advancements, Coreline Soft is positioned as a leader in this transformative journey, shaping the future of medical diagnostics.